Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 622 shares of Trupanion stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total transaction of $32,723.42. Following the completion of the transaction, the chief financial officer now directly owns 9,867 shares in the company, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Trupanion Stock Performance
NASDAQ:TRUP opened at $53.31 on Friday. The firm has a market capitalization of $2.26 billion, a PE ratio of -166.59 and a beta of 1.69. Trupanion, Inc. has a 1 year low of $19.69 and a 1 year high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm’s fifty day simple moving average is $49.94 and its 200 day simple moving average is $40.22.
Trupanion (NASDAQ:TRUP – Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.06) by $0.09. The company had revenue of $327.50 million for the quarter, compared to the consensus estimate of $321.79 million. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%. The firm’s revenue was up 14.6% compared to the same quarter last year. During the same period last year, the business posted ($0.10) earnings per share. On average, sell-side analysts anticipate that Trupanion, Inc. will post -0.23 EPS for the current year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
Several equities analysts have weighed in on the stock. Northland Securities lifted their price objective on shares of Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Piper Sandler increased their price target on shares of Trupanion from $45.00 to $57.00 and gave the stock a “neutral” rating in a research report on Thursday, October 31st. Evercore ISI upgraded shares of Trupanion to a “strong-buy” rating in a research note on Friday, August 9th. Stifel Nicolaus increased their target price on shares of Trupanion from $30.00 to $40.00 and gave the stock a “hold” rating in a research report on Monday, September 23rd. Finally, Bank of America upped their price target on shares of Trupanion from $47.00 to $56.00 and gave the stock a “buy” rating in a research note on Friday, September 20th. Three equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, Trupanion has an average rating of “Moderate Buy” and a consensus price target of $44.67.
Get Our Latest Research Report on Trupanion
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- The How And Why of Investing in Oil Stocks
- 3 Penny Stocks Ready to Break Out in 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.